LSE - Delayed Quote GBp

Avacta Group Plc (AVCT.L)

33.60
-1.40
(-4.00%)
At close: June 13 at 5:10:34 PM GMT+1

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Ms. Anne McGurk Joint Managing Director of Launch Diagnostics -- -- --
Mr. Sebastien Goenen Chief Operating Officer of Coris BioConcept -- -- --

Avacta Group Plc

Scale Space, White City Imperial College Campus
58 Wood Lane
London, W12 7RZ
United Kingdom
44 203 9110353 https://www.avacta.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
151

Description

Avacta Group Plc engages in research and development activities within the therapeutics business, focusing on the development of cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, the rest of Europe, and internationally. The company operates through the Therapeutics segment. It provides its proprietary Affimer and pre|CISION technology platforms, which are used to deliver a portfolio of differentiated therapeutic and diagnostic products that address various markets. The company is developing AVA6000, a peptide drug conjugate form of doxorubicin, which is in Phase I clinical trials for treating locally advanced or metastatic solid tumors; AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor, directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100, which is designed to drive localization to FAP-expressing tumors, with the second Affimer domain binding albumin to improve pharmacokinetics by increasing plasma half-life. The company has a collaboration agreement with LG Chem for developing and commercializing Affimer-based therapeutics. Avacta Group Plc was incorporated in 2003 and is headquartered in London, United Kingdom.

Corporate Governance

Avacta Group Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 6, 2025 at 10:59 AM UTC

Avacta Group Plc Earnings Date

Recent Events

Related Tickers